Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06591650
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-08
Brief Title:
Gemcitabine Hydrochloride Cisplatin Nab-Paclitaxel and Durvalumab in Treating Patients with Locally Advanced or Metastatic Gallbladder Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase II Study of Gemcitabine Cisplatin Nab-Paclitaxel and Durvalumab in Locally Advanced or Metastatic Gallbladder Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This phase II trail will evaluate the efficacy and safety of combining gemcitabine hydrochloride cisplatin nab-paclitaxel paclitaxel albumin-stabilized nanoparticle formulation with durvalumab in treating patients who have locally advanced or metastatic gallbladder cancer
Drugs used in chemotherapy such as gemcitabine hydrochloride cisplatin and nab-paclitaxel work in different ways to stop the growth of tumor cells either by killing the cells by stopping them from dividing or by stopping them from spreading Durvalumab is a type of drug called a monoclonal antibody which selectively blocks PD-L1 binding to PD-1 This anti-PD-L1 treatment works by allowing the immune system to detect your cancer and reactivates the immune response
Drugs used in chemotherapy such as gemcitabine hydrochloride cisplatin and nab-paclitaxel work in different ways to stop the growth of tumor cells either by killing the cells by stopping them from dividing or by stopping them from spreading Durvalumab is a type of drug called a monoclonal antibody which selectively blocks PD-L1 binding to PD-1 This anti-PD-L1 treatment works by allowing the immune system to detect your cancer and reactivates the immune response
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None